used in traditional Chinese, Ayurvedic, and Thai medication. Conolidine could depict the start of a completely new era of chronic pain administration. It's now being investigated for its consequences within the atypical chemokine receptor (ACK3). Within a rat model, it was uncovered that a competitor molecule binding to ACKR3 resulted in inhibition